VIRGINIA HOLMES: Open Payments
NPI 1912928359 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 19 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $66 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Corium, LLC | 3 | $37 |
| Amgen Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $24 |
| Astellas Pharma US Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: JARDIANCE, MOUNJARO, Azstarys, REPATHA, Wegovy, Veozah, SHINGRIX, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
